0.919
price up icon8.50%   0.072
pre-market  Vorhandelsmarkt:  .95   0.031   +3.37%
loading
Schlusskurs vom Vortag:
$0.847
Offen:
$0.86
24-Stunden-Volumen:
519.41K
Relative Volume:
0.68
Marktkapitalisierung:
$8.54M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.1386
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
+3.27%
1M Leistung:
-79.16%
6M Leistung:
-67.75%
1J Leistung:
-46.57%
1-Tages-Spanne:
Value
$0.81
$0.9307
1-Wochen-Bereich:
Value
$0.6358
$1.00
52-Wochen-Spanne:
Value
$0.6358
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Firmenname
iBio Inc
Name
Telefon
302-355-0650
Name
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
IBIO's Discussions on Twitter

Vergleichen Sie IBIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IBIO
iBio Inc
0.919 8.54M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-28 Eingeleitet Chardan Capital Markets Buy
2021-11-29 Eingeleitet JMP Securities Mkt Outperform
2021-01-22 Eingeleitet Cantor Fitzgerald Overweight
2020-06-26 Eingeleitet Alliance Global Partners Buy

iBio Inc Aktie (IBIO) Neueste Nachrichten

pulisher
07:24 AM

Analytical Overview: TMC the metals company Inc (TMC)’s Ratios Tell a Financial Story - DWinneX

07:24 AM
pulisher
07:24 AM

Financial Metrics Unveiled: CISO Global Inc (CISO)’s Key Ratios in the Spotlight - DWinneX

07:24 AM
pulisher
Apr 25, 2025

iBio - The Pharma Letter

Apr 25, 2025
pulisher
Apr 25, 2025

AstralBio - The Pharma Letter

Apr 25, 2025
pulisher
Apr 24, 2025

iBio Inc (IBIO) expanding its growth trajectory ahead - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Monitoring iBio Inc (IBIO) after recent insider movements - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

In the Green: iBio Inc (IBIO) Closes at 0.70, Up/Down -17.43 from Previous Day - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Ibio Inc Enters Exclusive License Agreement With AstralBio - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

iBio Enters Licensing Agreement for Obesity Treatment - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

iBio Inc (IBIO) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Breaking down IBIO’s current quarter earnings estimates - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Revolutionary AI-Discovered Obesity Drug: iBio Licenses First-Ever Activin E Antibody in $28M Deal - Stock Titan

Apr 22, 2025
pulisher
Apr 22, 2025

Porch Group Inc (PRCH) Stock: A Year of Stock Market Dynamics - investchronicle.com

Apr 22, 2025
pulisher
Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia

Apr 16, 2025
pulisher
Apr 08, 2025

iBio Highlights Advancements in Obesity Antibody Programs - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

iBio Inc (NASDAQ: IBIO): Time To Buy Over The Next Few Months - Marketing Sentinel

Apr 08, 2025
pulisher
Apr 07, 2025

iBio reports promising data on obesity treatment antibody By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

iBio reports promising data on obesity treatment antibody - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Where Do Analysts Think The iBio Inc (NASDAQ: IBIO) Is Going - stocksregister.com

Apr 07, 2025
pulisher
Apr 07, 2025

iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish - MSN

Apr 07, 2025
pulisher
Apr 07, 2025

Ibio reports preclinical results for antibodies in cardiometabolic and obesity pipeline - BioWorld MedTech

Apr 07, 2025
pulisher
Apr 07, 2025

Ibio IncOn Track For Regulatory Submission For Ibio-600 In Q1 2026 - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

iBio Reveals Promising Study Results for IBIO-600 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

iBio announces data from non-human primate PK study of IBIO-600 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

Game-Changing Clinical Data: iBio's New Drug Combines Muscle Growth with Massive Weight Loss - Stock Titan

Apr 07, 2025
pulisher
Apr 06, 2025

Senior Mining ExecutiveFrederic Mercier-Langevin to Join Patriot Battery Metals - The Globe and Mail

Apr 06, 2025
pulisher
Apr 03, 2025

Hartford Insurance Group Inc.(The) [HIG] Officer makes an insider purchase of 1,144 shares worth 0.14 million. - knoxdaily.com

Apr 03, 2025
pulisher
Apr 02, 2025

Galaxy Digital UK Secures FCA License, Expanding Derivatives Trading Capabilities in London - The Globe and Mail

Apr 02, 2025
pulisher
Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025
pulisher
Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025
pulisher
Mar 04, 2025

IBIO Stock Price and Chart — NASDAQ:IBIO - TradingView

Mar 04, 2025
pulisher
Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025
pulisher
Mar 03, 2025

$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq

Mar 03, 2025
pulisher
Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

iBio Inc [IBIO] gain 106.12% so far this year. What now? - dbtnews.com

Feb 28, 2025
pulisher
Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025
pulisher
Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025
pulisher
Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025
pulisher
Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025

Finanzdaten der iBio Inc-Aktie (IBIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):